Biotech

All Articles

AstraZeneca pays CSPC $100M for preclinical heart disease medication

.AstraZeneca has settled CSPC Drug Team $100 thousand for a preclinical heart disease drug. The offe...

Zephyrm seeks Hong Kong IPO to cash phase 3 tissue therapy tests

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, submission (PDF) for an ...

Frazier Life Sciences gathers $630M for small, mid-cap biotechs

.Frazier Everyday life Sciences has sourced an even further $630 million for its own fund focused on...

GigaGen gathers around $135M BARDA money to hammer botox

.Antitoxin enthusiast GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its o...

GPCR organization Septerna declare IPO on durability of preclinical information

.Septerna is about to learn just how a biotech without "any sort of purposeful medical information" ...

Kurma finalizes initially $154M loot for largest biotech fund yet

.International VC organization Kurma Partners has actually revealed its newest biotech fund, with 14...

Prothena advertises one exec while another leaves-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of significant leadership hirings, firings and a...

Editas cashes in on Vertex Cas9 licensing civil liberties for $57M

.Against the background of a Cas9 license war that refuses to die, Editas Medication is cashing in a...

Ultragenyx tweaks genetics therapy dosing to dial up efficacy

.A minority of clients taking Ultragenyx Drug's Wilson disease gene treatment UX701 have come off st...

Biopharma cutback cost maintains in Q3: Intense Biotech review

.As summer warm relies on cool down winds, hopes that this year would certainly bring common busines...